Top Markets
#1 Orochi Network Orochi Network +75.87%
#2 Bitway Bitway +26.98%
#3 Audiera Audiera +26.10%
#4 RSK Infrastructure Framework RSK Infrastructure Framework +18.60%
#5 Pharos Pharos +15.97%
#6 SOON SOON +15.75%
#7 DeXe DeXe +14.77%
#8 Cheems Token Cheems Token +14.21%
#9 Taiko Taiko +13.85%
#10 Manadia Manadia +13.47%
Coin of the day
Orochi Network Orochi Network
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rang in aandelen #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Aandeelprijs
$50.93
Marktkapitalisatie
$226.32B
Verandering (1 dag)
2.54%
Verandering (1 jaar)
-26.19%
Land
DK
Handel Novo Nordisk A/S (NVO)

Categorie

Healthcare
Aandelsplitsingen voor Novo Nordisk A/S (NVO)
Het aandeel Novo Nordisk A/S (symbool: NVO) heeft in totaal 5 splitsingen ondergaan.
De meest recente splitsing vond plaats op Sep 20, 2023.
Eén aandeel NVO dat vóór Apr 18, 1994 werd gekocht, staat nu gelijk aan 200 aandelen NVO.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2023-09-20 2:1 x2 x200
2014-01-09 5:1 x5 x100
2007-12-17 2:1 x2 x20
2001-04-11 5:2 x2.5 x10
1994-04-18 4:1 x4 x4
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 0 -
US
UCB SA UCB SA
UCB SA
UCB.BR
 0 -
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
ALNY.US
 0 -
US